1. Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
   Qihai Sui et al, 2022, Journal of Translational Medicine CrossRef
2. Relations between approved platinum drugs and non-coding RNAs in mesothelioma
   Bernhard Biersack, 2018, Non-coding RNA Research CrossRef
3. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
   Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef
4. miR-203 Inhibits the Invasion and EMT of Gastric Cancer Cells by Directly Targeting Annexin A4
   Jianye Li et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
5. miR‑3120‑5p acts as a diagnostic biomarker in non‑small cell lung cancer and promotes cancer cell proliferation and invasion by targeting KLF4
   Hongwei Xu et al, 2018, Molecular Medicine Reports CrossRef
6. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
   Dominika Kazmierczak et al, 2020, International Journal of Molecular Sciences CrossRef
7. Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2
   Zhengxiang Huang et al, 2021, Journal of Chemotherapy CrossRef
8. Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy
   Surya Kant Tripathi et al, 2019, AGO-Driven Non-Coding RNAs CrossRef
9. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition
   Qianqian Shao et al, 2018, Gene CrossRef
10. Current updates on microRNAs as regulators of chemoresistance
    Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
11. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma
    Bernhard Biersack, 2018, Non-coding RNA Research CrossRef
12. Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
    Dimitri Papukashvili et al, 2021, Cells CrossRef
13. Dickkopf‐1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV‐positive cancer cells in a JNK‐dependent manner
    Kristin Frensemeier et al, 2022, International Journal of Cancer CrossRef
14. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Milad Ashrafizadeh et al, 2021, Cellular Signalling CrossRef
15. Retraction: Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
    null null, 2021, PLOS ONE CrossRef
16. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
    Haibin Yan et al, 2018, Anti-Cancer Drugs CrossRef
17. Circ_0006220 promotes non-small cell lung cancer progression via sponging miR-203-3p and regulating RGS17 expression
    Shaochun Wang et al, 2022, Human & Experimental Toxicology CrossRef